Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
OTC: GZPHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hong Li
- Employees
- 28,138
- Headquarters
- Guangzhou, China
- IPO year
- 2010
- Market cap
- $6.2B
- Website
- https://www.gybys.com.cn
Loading GZPHF…
Loading profile data…Frequently asked questions about GZPHF
What does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) do?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF), operating with its various subsidiaries, is a diversified pharmaceutical conglomerate primarily engaged in the research, development, manufacturing, and global distribution of a broad spectrum of medical products. This includes traditional Chinese patented medicines, Western p...
Where does GZPHF trade?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) trades on the Other OTC.
What sector is GZPHF in?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited?
Hong Li is the chief executive officer of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF).
Where is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited headquartered?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is headquartered in China.
Does GZPHF pay a dividend?
Yes — Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) paid a trailing twelve-month dividend of USD 0.12 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did GZPHF go public?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) completed its initial public offering in 2010.